Cellares
Focus: Cellares develops manufacturing technology platforms for cell and gene therapies, positioned as a B2B enabler in the rapidly growing cell therapy space. The company operates at Series C+ stage with 201-500 employees based in San Francisco.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES C +
Employees
201-500
Open Jobs
22
Should You Work at Cellares?
AI assessmentIdeal for process engineers and supply chain professionals betting on cell therapy's scale; higher risk for those seeking clinical validation or revenue-driven stability.
Why Work Here
- Join a capital-efficient biotech focused on manufacturing infrastructure—a structural advantage as cell/gene therapy scales industry-wide
- Heavy hiring in Process Sciences (6 roles) signals active platform development and hands-on technical work
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cellares
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.